Literature DB >> 32201244

Nesfatin-1 in cardiovascular orchestration: From bench to bedside.

Tommaso Angelone1, Carmine Rocca2, Teresa Pasqua3.   

Abstract

Since the discovery of Nesfatin-1 in 2006, intensive research was finalized to further and deeper investigate the precise physiological functions of the peptide at both central and peripheral levels, rapidly enriching the knowledge regarding this intriguing molecule. Nesfatin-1 is a hypothalamic peptide generated via the post-translational processing of its precursor Nucleobindin 2, a protein supposed to play a role in many biological processes thanks to its ability to bind calcium and to interact with different intracellular proteins. Nesfatin-1 is mainly known for its anorexic properties, but it also controls water intake and glucose homeostasis. Recent experimental evidences describe the peptide as a possible direct/indirect orchestrator of central and peripheral cardiovascular control. A specific Nesfatin-1 receptor still remains to be identified although numerous studies suggest that the peptide activates extra- and intracellular regulatory pathways by involving several putative binding sites. The present paper was designed to systematically review the latest findings about Nesfatin-1, focusing on its cardiovascular regulatory properties under normal and physiopathological conditions. The hope is to provide the conceptual basis to consider Nesfatin-1 not only as a pleiotropic neuroendocrine molecule, but also as a homeostatic modulator of the cardiovascular function and with a crucial role in cardiovascular diseases.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarker; Cardiovascular diseases; Feeding behavior; Nesfatin-1; Nucleobindin 2

Mesh:

Substances:

Year:  2020        PMID: 32201244     DOI: 10.1016/j.phrs.2020.104766

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  4 in total

1.  Plasma Nesfatin-1: Potential Predictor and Diagnostic Biomarker for Cognitive Dysfunction in T2DM Patient.

Authors:  Dandan Xu; Yue Yu; Yayun Xu; Jinfang Ge
Journal:  Diabetes Metab Syndr Obes       Date:  2021-08-10       Impact factor: 3.168

2.  Elevated Nesfatin-1 Level in Synovium and Synovial Fluid is Associated with Pro-Inflammatory Cytokines in Patients with Rheumatoid Arthritis.

Authors:  Shuo Zhang; Genxiang Rong; Yayun Xu; Juehua Jing
Journal:  Int J Gen Med       Date:  2021-09-07

3.  Plasma nesfatin-1 and DDP-4 levels in patients with coronary artery disease: Kozani study.

Authors:  Nikolaos P E Kadoglou; Emmanouil Korakas; Stylianos Lampropoulos; Eirini Maratou; George Kassimis; Nikolaos Patsourakos; Panagiotis Plotas; Paraskevi Moutsatsou; Vaia Lambadiari
Journal:  Cardiovasc Diabetol       Date:  2021-08-13       Impact factor: 9.951

4.  Nesfatin-1 Receptor: Distribution, Signaling and Increasing Evidence for a G Protein-Coupled Receptor - A Systematic Review.

Authors:  Sophia Kristina Rupp; Ellen Wölk; Andreas Stengel
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-10       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.